Holtsberg; Frederick Wayne

Patent Applications and Registrations

Patent applications and USPTO patent grants for Holtsberg; Frederick Wayne.The latest application filed is for "broadly neutralizing antibody targeting the ebolavirus glycoprotein internal fusion loop".

Company Profile

3.6.10

Holtsberg; Frederick Wayne - Taneytown MD
Holtsberg, Frederick Wayne - Nicholasville KY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Broadly neutralizing antibody targeting the ebolavirus glycoprotein internal fusion loop Grant 11,186,626 - Aman , et al. November 30, 2	2021-11-30
Non-human primate-derived pan-ebola and pan-filovirus monoclonal antibodies directed against envelope glycoproteins Grant 10,611,827 - Aman , et al.	2020-04-07
Broadly Neutralizing Antibody Targeting The Ebolavirus Glycoprotein Internal Fusion Loop App 20200040065 - AMAN; Mohammad Javad ; et al.	2020-02-06
Toxoid peptides derived from phenol soluble modulin, delta toxin, superantigens, and fusions thereof Grant 10,174,085 - Aman , et al. J	2019-01-08
Pan-ebola And Pan-filovirus Protective Epitopes, Antibodies, And Antibody Cocktails App 20180237502 - Aman; Mohammad Javad ; et al.	2018-08-23
Toxoid Peptides Derived From Phenol Soluble Modulin, Delta Toxin, Superantigens, and Fusions Thereof App 20180148482 - Aman; Mohammad Javad ; et al.	2018-05-31
Equine Immunoglobulin Compositions And Uses For Treating Filovirus-mediated Diseases App 20180022790 - HOLTSBERG; Frederick Wayne ; et al.	2018-01-25
Non-human Primate-derived Pan-ebola And Pan-filovirus Monoclonal Antibodies Directed Against Envelope Glycoproteins App 20170334973 - AMAN; Mohammad Javad ; et al.	2017-11-23
Toxoid peptides derived from phenol soluble modulin, delta toxin, superantigens, and fusions thereof Grant 9,815,872 - Aman , et al. November 14, 2	2017-11-14
Toxoid Peptides Derived from Phenol Soluble Modulin, Delta Toxin, Superantigens, and Fusions Thereof App 20160185829 - Aman; Mohammad Javad ; et al.	2016-06-30
Peg-Modified Uricase App 20050226859 - Ensor, Charles Mark ; et al.	2005-10-13
PEG-modified uricase Grant 6,913,915 - Ensor , et al. July 5, 2	2005-07-05
Methods for predicting sensitivity of tumors to arginine deprivation App 20050063942 - Clark, Mike A. ; et al.	2005-03-24
Novel mutated form of arginine deiminase App 20040258675 - Ensor, Charles Mark ; et al.	2004-12-23
Mutated form of arginine deiminase Grant 6,635,462 - Ensor , et al. October 21, 2	2003-10-21
PEG-modified uricase App 20030082786 - Ensor, Charles Mark ; et al.	2003-05-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.